Heiko Schuster

Paul Ehrlich Str. 15
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens.

Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens.

Journal: mAbs
Published: September 01, 2026

Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

Journal: Nature medicine
Published: June 19, 2026

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

Journal: Nature medicine
Published: April 17, 2026

Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Journal: Nature medicine
Published: April 29, 2025

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Journal: Nature medicine
Published: August 05, 2024

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.

Journal: Blood cancer discovery
Published: February 03, 2023

Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.

Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.

Journal: Science translational medicine
Published: August 31, 2022

The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer Patients.

The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer Patients.

Journal: Digestive diseases and sciences
Published: May 06, 2022

Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.

Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 14, 2021

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo.

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo.

Journal: Cancer immunology, immunotherapy : CII
Published: June 25, 2021

Pitfalls in HLA Ligandomics-How to Catch a Li(e)gand.

Pitfalls in HLA Ligandomics-How to Catch a Li(e)gand.

Journal: Molecular & cellular proteomics : MCP
Published: December 17, 2020

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues.

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues.

Journal: iScience
Published: November 10, 2020
Showing 1-12 of 49

Last Updated: 09/26/2026